Evaluating Slow-Acting Drugs for Osteoarthritis
Author Information
Author(s): Bruyère Olivier, Burlet Nansa, Delmas Pierre D, Rizzoli René, Cooper Cyrus, Reginster Jean-Yves
Primary Institution: WHO Collaborating Center for the Public Health Aspect of Musculoskeletal Disorders, University of Liege, Belgium
Hypothesis
What are the recommendations for the use of symptomatic slow-acting drugs in osteoarthritis?
Conclusion
Chondroitin sulfate, diacereine, glucosamine sulfate, avocado/soybean unsaponifiables, and hyaluronic acid may be beneficial for managing osteoarthritis symptoms.
Supporting Evidence
- Chondroitin sulfate showed significant pain reduction in a meta-analysis of 20 trials.
- Diacerein was found to be superior to placebo in reducing pain and improving function.
- Glucosamine sulfate demonstrated a significant effect on pain improvement compared to placebo.
- Hyaluronic acid showed net benefits in pain reduction and physical function.
- Avocado/soybean unsaponifiables were well tolerated and showed significant improvement in function.
Takeaway
Some medicines can help people with joint pain feel better and move easier, and they are safe to use.
Methodology
A systematic review of meta-analyses and randomized controlled trials was conducted to evaluate the effectiveness of various slow-acting drugs in osteoarthritis.
Potential Biases
Potential bias due to authors reviewing their own work and the influence of pharmaceutical funding.
Limitations
Some studies had methodological flaws, including unclear randomization and blinding, which may affect the quality of evidence.
Participant Demographics
The study included adults with osteoarthritis, primarily affecting the hip and knee.
Statistical Information
P-Value
p<0.01
Confidence Interval
Not specified
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website